Acute Kidney Damage in Pregnancy: Etiopathogenesis, Diagnostics and Basic Principles of Treatment

1. Asharya A, Santos J, Linde B, Anis K. Acute Kidney Injury in Pregnancy-Current Status. Adv Chronic Kidney Dis 2013; 20(3): 215-22.10.1053/j.ackd.2013.02.00223928385Search in Google Scholar

2. Jim B, Garovic VD. Acute Kidney Injury. SeminNephrol 2017; 37(4): 378-85.Search in Google Scholar

3. Jim B, Karumanchi SA. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. SeminNephrol 2017; 37(4): 386-97.10.1016/j.semnephrol.2017.05.01128711078Search in Google Scholar

4. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10(8): 466-80.10.1038/nrneph.2014.102589315025003615Search in Google Scholar

5. Naljayan MV, Karumanchi SA. New Developments in the Pathogenesis of Preeclampsia. Adv Chronic Kidney Dis 2013; 20(3): 265-70.10.1053/j.ackd.2013.02.003410733823928392Search in Google Scholar

6. Chaiworapongsa T, Chaemsaithong P, Korzeniewski SJ, Yeo L, Romero R. Pre-eclampsia part 2: prediction, prevention and management. Nat Rev Nephrol 2014; 10(9): 531-40.10.1038/nrneph.2014.103589879725003612Search in Google Scholar

7. Petrović D. Preeklampsija i eklampsija: etiopatogeneza, dijagnostika i lečenje. U: Trudnoća i bubreg u kliničkojpraksi. Ed. Petrović D. Kragujevac, Interprint, Fakultetmedicinskihnauka 2016: 47-65.Search in Google Scholar

8. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy and Childbirth 2009; 9(1): 8-23. [doi: 10.1186/1471-2393-9-8].10.1186/1471-2393-9-8265485819245695Search in Google Scholar

9. Simetka O, Klat J, Gumulec J, Dolezalkova E, Salounova D, Kacerovsky M. Early identification of women with HELLP syndrome who need plasma exchange after delivery. Transfus Apher Sci 2015; 52(1): 54-9.10.1016/j.transci.2014.12.00925571785Search in Google Scholar

10. Erkurt MA, Berktas HB, Kuku I, Kaya E, Koroglu M, Nizam I, et al. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange. Transfus Apher Sci 2015; 52(2): 194-8.10.1016/j.transci.2014.12.02625595543Search in Google Scholar

11. Petrović D, Tirmenštajn-Janković B, Živanović M, Petrović-Nikolić A, Nikolić A, Đurđević P, et al. Plazmafereza: osnovni principi i klinički značaj u trudnoći. Timoč Med Glas 2016; 41(1): 41-54.Search in Google Scholar

12. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J ClinApher 2016; 31(3): 149-338.10.1002/jca.2147027322218Search in Google Scholar

13. Tran TT, Ahn J, Reau N. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol 2016; 11(2): 176-94.10.1038/ajg.2015.43026832651Search in Google Scholar

14. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol 2016; 64(4): 933-45.10.1016/j.jhep.2015.11.03026658682Search in Google Scholar

15. Licata A, Calvaruso V, Primignani M, Morisco F, Bugianesi E, Invernizzi P, et al. AISF position paper on liver disease and pregnancy. Dig Liver Dis 2015; 48(2): 120-37.Search in Google Scholar

16. Fakhouri F, Vercel C, Fremeaux-Bacchi V. Obstretic Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy. Clin J Am SocNephrol 2012; 7(12): 2100-6.10.2215/CJN.1312121122879435Search in Google Scholar

17. Kavanagh D, Goodship TH, Richards A. Atypical Hemolityc Uremic Syndrome. Semin Nephrol 2013; 33(6): 508-30.10.1016/j.semnephrol.2013.08.003386395324161037Search in Google Scholar

18. NorisM, Remuzzi G. Overview of Complement Activation and Regulation. Semin Nephrol 2013; 33(6): 479-92.10.1016/j.semnephrol.2013.08.001382002924161035Search in Google Scholar

19. Petrović D, Čanović P, Mijailović Ž, Popovska-Jovičić B, Jaćović S. Hemolitičko-uremijski sindrom: etiopatogeneza, dijagnostika i osnovni principi lečenja. Med Čas 2015; 49(2): 59-65.Search in Google Scholar

20. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J ClinApher 2016; 31(3): 149-338.10.1002/jca.2147027322218Search in Google Scholar

21. Clark WF, Huang SHS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM. Plasmapheresis for the treatment of kidney diseases. Kidney Int 2016; 90(5): 974-84.10.1016/j.kint.2016.06.00927498206Search in Google Scholar

22. Andries G, Karass M, Yandrapilli S, Linder K, Liu D, Nelson J, et al. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab. ExpHematolOncol 2017; 6: 4. Doi: 10.1186/s40164-017-0064-7.10.1186/s40164-017-0064-7523717728101432Search in Google Scholar

23. De Sousa-Amorim E, Pelicano MB, Quintana LF, Campistol JM. Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management. J Nephrol 2015; 28(5): 641-5.10.1007/s40620-015-0173-525712233Search in Google Scholar

24. Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V on behalf of the French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolyticuraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 2012; 8(11): 643-57.10.1038/nrneph.2012.21423026949Search in Google Scholar

25. Keating GM. Eculizumab: A Review of Its Use in Atypical HaemolyticUraemic Syndrome. Drugs 2013; 73(18): 2053-66.10.1007/s40265-013-0147-724249647Search in Google Scholar

26. Gately R, San A, Kurtkoti J, Parnham A. Life-threatening pregnancy-associated atypical haemoliticuraemic syndrome and its response to eculizumab. Nephrology 2017; 22(Suppl 1): 32-5.10.1111/nep.1293828176475Search in Google Scholar

27. Trestioreanu AZ, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningoccal infections. Cochrane Database Syst Rev 2013; 10: CD004785. Doi:10.1002/14651858.CD004785.pub5.10.1002/14651858.CD004785.pub5669848524163051Search in Google Scholar

28. Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014; 124(2): 211-9.10.1182/blood-2014-02-55313124859360Search in Google Scholar

29. Todorović Ž, Jovanović M, Todorović D, Petrović D, Đurđević P. Thrombotic thrombocytopenic purpura: etiopathogenesis, diagnostics and basic principles of treatment. Ser J ExpClin Res 2017; 18(1): 61-8.10.1515/sjecr-2016-0026Search in Google Scholar

30. Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood 2015; 125(25): 3860-7.10.1182/blood-2014-11-551580447311525784681Search in Google Scholar

31. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117(5): 1499-506.10.1182/blood-2010-07-29544421098742Search in Google Scholar

32. Petrović D. Akutno oštećenje bubrega: etiologija, dijagnostika i lečenje.Medicinska Istraživanja 2011;45(3):7-13.Search in Google Scholar

33. Acharya A. Management of Acute Kidney Injury in Pregnancy for the Obstetrician. ObstetGynecolClin N Am 2016; 43(4): 747-65.10.1016/j.ogc.2016.07.00727816158Search in Google Scholar

34. Machado S, Figueiredo N, Borges A, Sao Jose Pais M, Freitas L, Moura P. Acute kidney injury in pregnancy: a clinical challenge. J Nephrol 2012; 25(1): 19-30.10.5301/jn.500001321928228Search in Google Scholar